SCHEMBL1649523

SCHEMBL1649523

C#CCC(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL846593 1.00
SCHEMBL17973540 1.00
Hydrochloric Acid SCHEMBL10662624 0.97
SCHEMBL14950815 0.79
SCHEMBL1308390 0.79
SCHEMBL4970428 0.78 GABRR1 (0.46)
SCHEMBL6725108 0.77
SCHEMBL10662614 0.77
SCHEMBL17352411 0.77
SCHEMBL6725209 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2681595-B1 PROCESS FOR PREPARING MOLDED OPTICAL ARTICLES PPG IND OHIO INC (US) 2015-02-18 EP claimed
EP-2559721-B1 Compositions and articles prepared from thioether functional oligomeric polythiols PPG IND OHIO INC (US) 2015-01-07 EP claimed
EP-2688868-A1 METHOD FOR THE SYNTHESIS OF DHA Phenomenome Discoveries Inc. (CA) 2014-01-29 EP claimed
US-20140012024-A1 METHOD FOR THE SYNTHESIS OF DHA PHENOMENOME DISCOVERIES INC. (CA) 2014-01-09 US claimed
EP-2016115-B1 COMPOSITIONS AND ARTICLES PREPARED FROM THIOETHER FUNCTIONAL OLIGOMERIC POLYTHIOLS PPG IND OHIO INC (US) 2013-01-02 EP claimed
WO-2012126088-A1 METHOD FOR THE SYNTHESIS OF DHA PHENOMENOME DISCOVERIES INC. (CA) 2012-09-27 WO claimed
CN-1185746-C Electrolyte for secondary lithium cell and secondary lithium cell therewith UBE INDUSTRIES (JP) 2005-01-19 CN claimed
CN-1322027-A Electrolyte for secondary lithium cell and secondary lithium cell therewith UBE INDUSTRIES (JP) 2001-11-14 CN claimed
EP-0389617-B1 TREATMENT OF RHODIUM CATALYSTS UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) 1993-03-17 EP claimed
EP-0357997-B1 REACTIVATION OF HYDROFORMYLATION CATALYSTS UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) 1992-11-25 EP claimed
US-20240247106-A1 BIODEGRADABLE DRUG-POLYMER CONJUGATE POLYACTIVA PTY LTD (AU) 2024-07-25 US disclosed
US-11787906-B2 Biodegradable drug-polymer conjugate POLYACTIVA PTY LTD (AU) 2023-10-17 US disclosed
CN-109963870-B anti-B7-H3 antibodies and antibody drug conjugates 艾伯维公司 2023-07-28 CN disclosed
CN-116284404-A anti-B7-H3 antibodies and antibody drug conjugates 艾伯维公司 2023-06-23 CN disclosed
CN-116173232-A anti-CD 98 antibodies and antibody drug conjugates 艾伯维公司 2023-05-30 CN disclosed
US-6171995-B1 Catalyst mixture for ring-opening metathesis polymerization CIBA SPECIALTY CHEMCIALS CORPORATION 2001-01-09 US disclosed
US-6150303-A Substituted 3-phenylisoxazolines BASF AKTIENGESELLSCHAFT (DE) 2000-11-21 US disclosed
CN-1189824-A 1-amino-3-benzyluracils BASF AG (DE) 1998-08-05 CN disclosed
EP-0844263-A2 Catalytic mixture for ring-opening metathesis polymerization Ciba SC Holding AG (CH) 1998-05-27 EP disclosed
US-4724236-A FOR TREATING THROMBOEBOLIC DISEASE, BRADYCARDIA OR BRADYARRYTHMIA KARL THOMAE GMBH (DE) 1988-02-09 US disclosed